|Articles|March 15, 2020
- BioPharm International-03-15-2020
- Volume 2020 eBook
- Issue 2
Pharmacopoeia Compliance: Putting It All Together; What Is on the Horizon (eBook)
Author(s)J. Mark Wiggins, Joseph A. Albanese
This final article in the series has two purposes: to summarize all the considerations that go into a company’s compendial affairs program and to look ahead at topics that will likely result in further evolution in the pharmacopoeias around the world.
Advertisement
Pharmacopoeia Compliance Series
Compliance with requirements published by pharmacopoeias around the world is a legal and regulatory requirement in those countries and regions in which the pharmacopoeia is applicable.
This final article in the series has two purposes: to summarize all the considerations that go into a company’s compendial affairs program and to look ahead at topics that will likely result in further evolution in the pharmacopoeias around the world.
This article is part of a series that will be published in 2019–2020.
Article Details
BioPharm International
eBook: Regulatory Sourcebook, March 2020
March 2020
Pages: 36–46
Citation
When referring to this article, please cite it as J.M. Wiggins and J.A. Albanese, “Pharmacopoeia Compliance: Putting It All Together; What Is on the Horizon," BioPharm International Regulatory Sourcebook eBook (March 2020).
Articles in this issue
over 5 years ago
Resources, Guidelines, and Guidance Documentsover 5 years ago
Regulatory and Standard Setting Organizationsover 5 years ago
Is There a “New Normal” for Drug Quality?over 5 years ago
Monograph Development: Why and When to Participate (eBook)over 5 years ago
A Practical Approach to Pharmacopoeia Compliance (eBook)over 5 years ago
Inside FDA’s New Gene and Cell Therapy GuidancesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
